| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Veracyte, Inc. (VCYT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. VCYT is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 318.6K | $12.88M | - | |
| CFO | 109.5K | $4.43M | - | |
| Other | 89.5K | $3.62M | - | |
| Other | 82.1K | $3.32M | - | |
| VP | 67.8K | $2.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Stapley Marc60 | Chief Executive Officer | Sell | 5,590 | $43.42 | $242,736.96 | -0.9% | -29.6% | -0.9% | |
| Dec 4, 2024 | Febbo Phillip G.63 | Chief Scientific &Med Officer | Sell | 3,934 | $44.09 | $173,447.31 | -4.6% | -22.6% | +7.5% | |
| Dec 4, 2024 | McGuire Annie46 | SVP, General Counsel | Sell | 18,699 | $44.02 | $823,178.60 | -20.4% | -22.6% | +7.5% | |
| Dec 3, 2024 | Leite John51 | Chief Commercial Officer-clia | Sell | 1,050 | $43.25 | $45,407.88 | -1.4% | -23.1% | +9.4% | |
| Dec 3, 2024 | Chambers Rebecca73 | Chief Financial Officer | Sell | 7,000 | $43.23 | $302,621.90 | -5.8% | -23.1% | +9.4% | |
| Dec 3, 2024 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 956 | $43.36 | $41,452.45 | -2.3% | -23.1% | +9.4% | |
| Nov 27, 2024 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 5,032 | $42.89 | $215,833.55 | -10.6% | -22.0% | +10.4% | |
| Nov 19, 2024 | Eastham Karin67 | Director | Sell | 14,731 | $38.34 | $564,768.40 | -15.8% | +3.2% | +2.0% | |
| Nov 12, 2024 | Chambers Rebecca73 | Chief Financial Officer | Sell | 15,275 | $38.34 | $585,663.36 | -10.9% | +9.6% | +10.6% | |
| Nov 12, 2024 | Epstein Robert S | Director | Sale+OE | 15,000 | $38.32 | $574,830.00 | -25.2% | +9.6% | +10.6% |